ENvue Medical (FEED) Long-Term Deferred Tax (2014 - 2025)
ENvue Medical's (FEED) quarterly Long-Term Deferred Tax came in at $927000.0 in Q4 2025, down 90.94% year-on-year from $10.2 million in Q4 2024, and down 90.94% on a QoQ basis from $10.2 million in Q4 2024.
ENvue Medical (FEED) Long-Term Deferred Tax (2014 - 2025) Analysis & Trends
ENvue Medical (FEED) has 3 years of Long-Term Deferred Tax data on file, last reported at $927000.0 in Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax fell 90.94% year-over-year to $927000.0 in Q4 2025; TTM through Dec 2025 was $927000.0, a 90.94% decrease from a year earlier, with the FY2025 full-year figure at $927000.0, down 90.94% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $927000.0, down from $10.2 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for FEED reached as high as $10.2 million in Q4 2024 and fell as low as $927000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | ENvue Medical | 1.18 Mn | -1.09 Mn | -55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 927,000.00 |
| Dec 31, 2024 | 10.23 Mn |
| Dec 31, 2014 | 358,000.00 |